Moreover, recent studies have demonstrated the critical involvement of the c-Myc/NEAT1 axis in mediating the therapeutic efficacy of PDT in CRC through the miR-124/iASPP/p53 pathway.137 (Table 2). This evidence concerns the gene TP53 and colorectal carcinoma.